| 前收市價 | 43.20 |
| 開市 | 43.20 |
| 買盤 | 42.34 x 100 |
| 賣出價 | 42.42 x 100 |
| 今日波幅 | 41.51 - 43.86 |
| 52 週波幅 | 12.17 - 44.92 |
| 成交量 | |
| 平均成交量 | 963,271 |
| 市值 | 2.516B |
| Beta 值 (5 年，每月) | 1.63 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.36 |
| 業績公佈日 | 2024年8月02日 - 2024年8月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 43.76 |
Insider MonkeyTwist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript May 2, 2024 Twist Bioscience Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Twist Bioscience’s Fiscal 2024 Second Quarter Financial Results Conference Call. At this time, all participants […]
ZacksTwist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of 5.95% and 6.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
InvestorPlace3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Biotech stocks offer the opportunity to invest in life-saving treatments and drugs. So not only can you make massive gains but you are also investing in the advancement of modern medicine. But not all biotech companies are the same. Some are established pharmaceutical giants while others are pre-revenue startups that are banking on a drug breakthrough. What this means is that an FDA approval or denial can have major consequences on the stock. If you want to invest in biotech stocks, you will nee
